BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Aysun Ozkan, Ayse Erdogan, Odul Ozkan, Esra Manguoglu, Nadir Kiraz. Enhanced anticancer effect of cetuximab combined with stabilized silver ion solution in EGFR-positive lung cancer cellsTurkish Journal of Biochemistry 2019; 44(4): 426 doi: 10.1515/tjb-2018-0033
2
Marc A. Becker, Douglas Yee. EGFR Signaling Networks in Cancer Therapy2008; : 147 doi: 10.1007/978-1-59745-356-1_11
3
Minoru Haisa. The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancerJournal of International Medical Research 2013; 41(2): 253 doi: 10.1177/0300060513476585
4
Yu Kusada, Yoko Fujita-Yamaguchi. Affinity of anti-insulin-like growth factor Ι receptor antibody binding to the receptor altered by plant lectinsBioScience Trends 2011; 5(3): 93 doi: 10.5582/bst.2011.v5.3.93
5
Ferenc Sipos, Hajnal Székely, Imre Dániel Kis, Zsolt Tulassay, Györgyi Műzes. Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancerWorld Journal of Gastroenterology 2017; 23(46): 8109-8119 doi: 10.3748/wjg.v23.i46.8109
6
Qi Qi, Keqiang Ye. The roles of PIKE in tumorigenesisActa Pharmacologica Sinica 2013; 34(8): 991 doi: 10.1038/aps.2013.71
7
Erin A. Donovan, Shivaani Kummar. Role of insulin-like growth factor-1R system in colorectal carcinogenesisCritical Reviews in Oncology/Hematology 2008; 66(2): 91 doi: 10.1016/j.critrevonc.2007.09.003
8
Mario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, Chiara Pierantoni, Fotios Loupakis, Alberto Zaniboni, Eva Galizia, Lucio Giustini, Rosa Rita Silva, Renato Bisonni, Rossana Berardi, Simona Biagetti, Stefano Menzo, Alfredo Falcone, Italo Bearzi, Stefano Cascinu. Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecanInternational Journal of Cancer 2010; 127(8): 1941 doi: 10.1002/ijc.25193
9
Rong Zhang, Guo-Liang Xu, Yin Li, Long-Jun He, Li-Ming Chen, Guo-Bao Wang, Shi-Yong Lin, Guang-Yu Luo, Xiao-Yan Gao, Hong-Bo Shan. The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinomaJournal of International Medical Research 2013; 41(4): 1228 doi: 10.1177/0300060513487631
10
Rabea Oberthür, Henning Seemann, Julia Gehrig, Margret Rave-Fränk, Felix Bremmer, Rovena Halpape, Lena-Christin Conradi, Jens-Gerd Scharf, Peter Burfeind, Silke Kaulfuß. Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell deathCancer Letters 2017; 407: 93 doi: 10.1016/j.canlet.2017.08.009
11
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectivesWorld Journal of Gastroenterology 2008; 14(46): 7021-7032 doi: 10.3748/wjg.14.7021
12
Deeksha Vishwamitra, Suraj Konnath George, Ping Shi, Ahmed O. Kaseb, Hesham M. Amin. Type I insulin-like growth factor receptor signaling in hematological malignanciesOncotarget 2017; 8(1): 1814 doi: 10.18632/oncotarget.12123
13
Sarah Kraus, Nadir Arber. Colorectal cancer chemoprevention: Ready for practice?European Journal of Cancer 2009; 45: 360 doi: 10.1016/S0959-8049(09)70051-6
14
Ayunadirah Ayub, Wai Kien Yip, Heng Fong Seow. Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell lineBiomedicine & Pharmacotherapy 2015; 75: 40 doi: 10.1016/j.biopha.2015.08.031
15
Joseph A. Ludwig, Salah-Eddine Lamhamedi-Cherradi, Ho-Young Lee, Aung Naing, Robert Benjamin. Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug ResistanceCancers 2011; 3(3): 3029 doi: 10.3390/cancers3033029
16
Hong You, Geoffrey N. Gobert, Malcolm K. Jones, Wenbao Zhang, Donald P. McManus. Signalling pathways and the host-parasite relationship: Putative targets for control interventions against schistosomiasisBioEssays 2011; 33(3): 203 doi: 10.1002/bies.201000077
17
XIAO HONG BAO, YOSHIO NAOMOTO, HUI FANG HAO, NOBUYUKI WATANABE, KAZUFUMI SAKURAMA, KAZUHIRO NOMA, TAKAYUKI MOTOKI, YASUKO TOMONO, TAKUYA FUKAZAWA, YASUHIRO SHIRAKAWA, TOMOKI YAMATSUJI, JUNJI MATSUOKA, MUNENORI TAKAOKA. IGF-IR and its inhibitors in gastrointestinal carcinomas (Review)Oncology Letters 2010; 1(1): 195 doi: 10.3892/ol_00000036
18
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancerWorld Journal of Gastroenterology 2008; 14(1): 1-14 doi: 10.3748/wjg.14.1
19
Teresa Troiani, Erika Martinelli, Floriana Morgillo, Anna Capasso, Anna Nappi, Vincenzo Sforza, Fortunato Ciardiello. Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?Therapeutic Advances in Medical Oncology 2013; 5(1): 51 doi: 10.1177/1758834012462462
20
Scott C. Mayer, Annette L. Banker, Frank Boschelli, Li Di, Mark Johnson, Cynthia Hess Kenny, Girija Krishnamurthy, Kristina Kutterer, Franklin Moy, Susan Petusky, Malini Ravi, Diane Tkach, Hwei-Ru Tsou, Weixin Xu. Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatmentBioorganic & Medicinal Chemistry Letters 2008; 18(12): 3641 doi: 10.1016/j.bmcl.2008.04.044
21
Marc A. Becker, Douglas Yee. Insulin-like Growth Factors and Cancer2012; : 73 doi: 10.1007/978-1-4614-0598-6_4
22
Juan Wang, Fengxiang Huang, Zhun Bai, Bixia Chi, Jiacai Wu, Xu Chen. Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK PathwayInternational Journal of Molecular Sciences 2015; 16(8): 19851 doi: 10.3390/ijms160819851
23
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectivesWorld Journal of Gastroenterology 2008; 14(16): 2461-2473 doi: 10.3748/wjg.14.2461
24
Stella Nikolaou, Shengyang Qiu, Francesca Fiorentino, Shahnawaz Rasheed, Paris Tekkis, Christos Kontovounisios. The prognostic and therapeutic role of hormones in colorectal cancer: a reviewMolecular Biology Reports 2019; 46(1): 1477 doi: 10.1007/s11033-018-4528-6
25
H-B. Shan, R. Zhang, Y. Li, G-L. Xu, G-Y. Luo, X-Y. Gao, H-L. Yang. Expression of IGF-1R in Colorectal Polyps and its Role in Colorectal CarcinogenesisTechnology in Cancer Research & Treatment 2011; 10(4): 381 doi: 10.7785/tcrt.2012.500215
26
Christopher Christophi, Nadia Harun, Theodora Fifis. Liver Regeneration and Tumor Stimulation—A Review of Cytokine and Angiogenic FactorsJournal of Gastrointestinal Surgery 2008; 12(5): 966 doi: 10.1007/s11605-007-0459-6